SAVING LIVES AND CREATING IMPACT EU investment in poverty-related neglected diseases
1 2 3 What has the EU invested in How have developing countries What is the return on investment PRND R&D? benefitted? for Europe? EU Investment in Health and prosperity Growth and = + PRND R&D in developing competitiveness in countries the EU Levels of funding Health impact Jobs created Industrial • • • • • Nature of funding • Economic impact • Leveraged competitiveness • Research capacity investment • Health in the EU • Scientific • Integration excellence
1 What has the EU invested in PRND R&D? The EU invests € 341 million a year in PRND R&D 15% OF ALL FUNDING FOR PRND R&D
1 What has the EU invested in PRND R&D? Top Funders € 87m 2 nd € 93m UK 1 st € 53m EC 3 rd France
1 What has the EU invested in PRND R&D? Sweden 0.0054% Finland 0.0004% Member State Denmark 0.0042% UK Funding by GDP 0.0049% Ireland Netherlands 0.0047% 0.0035% Germany 0.0007% Belgium 0.0016% EU Luxembourg 0.0024% France USA Brazil India 0.0032% 0.0013% 0.01% 0.0017% 0.0017% Italy 0.0002% Spain 0.0013%
2 How have developing countries benefitted? MDG 1 MDG 2 MDG 3 MDG 4 Eradicate Extreme Achieve Universal Promote Gender Reduce Child Pharmaceutical Poverty and Hunger Primary Education Equality and Mortality Empower Women Innovation MDG 5 MDG 6 MDG 7 MDG 8 Combat HIV/AIDS, Ensure A Global Improve Maternal Health Malaria and other Environmental Partnership for diseases Sustainability Development
2 How have developing countries benefitted? EU investment has contributed to the creation of 43 new PRND products
2 How have developing countries benefitted? KEY PHARMACEUTICAL INNOVATIONS MALARIA 1.COARTEM 2.ASAQ INFECTS 216+ MILLION PEOPLE KILLS AROUND 655,000 PEOPLE 3.EUARTESIM Image Credit: Anne Heslop Photography
2 How have developing countries benefitted? 359 products in development 43% involving European developers FOR VACCINES ALONE, THERE ARE PROMISING CANDIDATES FOR BURULI ULCER, TUBERCULOSIS AND SCHISTOSOMIASIS
2 How have developing countries benefitted? International Centre for Diarrhoeal Disease Research, Bangladesh Key Developing Country Research Institutions in Africa & Asia Medical Research Ifakara Health Institute, Council, Tanzania Gambia Medical Research Unit Manhiça Health – Albert Schweitzer Research Centre, Hospital, Gabon Mozambique
3 What is the return on investment for Europe? EU investment created more than 13,000 jobs
3 What is the return on investment for Europe? Two-thirds of Europe’s PRND R&D funding is invested back into Europe
3 What is the return on investment for Europe? Industry € 0.53 Philanthropy € 0.45 € 1 € 2.05 Other gov’ts € 0.07
3 What is the return on Liverpool School of Tropical Statens Serum Institute Karolinska Institute Medicine investment for Europe? London School of Hygiene & Bernhard Nocht Institute for Tropical Medicine Tropical Medicine Top European Royal Tropical Institute Heidelberg University PRND Research Institutes University of Tübingen Institute of Tropical Medicine Swiss Tropical Institue of Institut Pasteur Barcelona Centre for International Health Research Public Health
3 What is the return on investment for Europe? 6x The European pharmaceutical industry invested six times more than the U.S. industry relative to annual revenues
Opportunity: Opportunity: Horizon 2020 Horizon 2020 Increased PRND R&D investment under Horizon 2020 will benefit both developing countries and Europe
Opportunity: Horizon 2020 Building Capacity in Collaboration & + Developing Countries partnerships EU Investment in = + + PRND R&D Quality Research Integrating Industry + Health and prosperity Growth and = + in developing competitiveness in countries the EU
Recommendations Recommendations 1 Increase investments in PRND R&D including an increased commitment from the EC under Horizon 2020
Recommendations 2 Retain and foster the distinctive benefits of its approach to funding PRND R&D
Recommendations 3 Improve specific aspects of its investment in PRND R&D, to ensure greater efficiency, impact and value
Thank you
Recommend
More recommend
